[[{"@type":["BlogPosting"],"@id":"https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/#BlogPosting","@context":{"@vocab":"http:\/\/schema.org\/","kg":"http:\/\/g.co\/kg"},"url":["https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/","https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/"],"publisher":[{"@id":"https:\/\/www.regionalcancercare.org\/"}],"author":[{"@type":"Organization","@id":"https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/#BlogPosting_author_Organization","name":"Regional Cancer Care Associates"}],"inLanguage":"en-US","image":[{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/#BlogPosting_image_ImageObject","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Microscope-Testing.jpg"}],"headline":"Applying the Gleason Score to Prostate Cancer","dateModified":"2021-11-11T14:32:49+00:00","datePublished":"2018-12-22T13:22:24+00:00","description":"To help understand prostate cancer, doctors use something called a Gleason grading system. Learn what it means over on the RCCA website.","articleBody":"\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\tDecember 22, 2018\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\nThe more we know about prostate cancer, the better we can treat it. That\u2019s why doctors at Regional Cancer Care Associates use something called the Gleason grading system. This system helps paint a clearer picture of how the cancer is going to behave and what types of treatment might work best for that individual patient.\nHow Prostate Cancer Is Categorized\nWhen someone is diagnosed with prostate cancer, doctors perform a series of tests to collect as much information as possible. Those tests may include a digital rectal exam, an MRI, a CT scan, a prostate-specific antigen (PSA) blood test, a transrectal ultrasound and a biopsy. Based on the results of these tests, the cancer is then assigned a stage and a grade.\nThe stage, such as Stage I or Stage IV cancer, tells us where the cancer is located inside the body. The grade, however, tells us how aggressive the prostate cancer is. The scores are divided as follows:\nLow risk (grades 2-6): Unlikely to grow or spreadMedium risk (grade 7): Likely to spread in a few yearsHigh risk (grades 8-10): Likely to spread at a rapid pace\nUnderstanding the Gleason Grading System\nTo determine a patient\u2019s Gleason score, a sample of their prostate cancer is collected during a biopsy. That sample is then studied under a microscope to figure out the cancer\u2019s cellular composition. A pathologist picks out the two most common types of cell patterns and assigns each of them a grade 1 through 5, with 5 being the most mutated. Those two grades are then added together. The lowest possible score is a 2 and the highest possible score is a 10 \u2013 although in practice, the lowest score that is given is a 6.\nWhat the Score Means for Prostate Cancer Patients\nDoctors will use the Gleason score, combined with the stage and the results from the PSA and other tests, to evaluate a patient\u2019s prognosis and create the best treatment plan possible. They\u2019ll also consider the individual\u2019s age, family history and overall health. While high-grade prostate cancer may be more difficult to treat, it just means that doctors and patients will have to fight back just as hard.\nHere at Regional Cancer Care Associates, oncologists are constantly looking for new ways to prevent, diagnose and treat prostate cancer. If you or a loved one is dealing with prostate cancer, make an appointment at your local RCCA office to get the best care available.\nwe are here for you\nFor more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.\nRELATED ARTICLES\nRegional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.\n\u00a9 2022 Regional Cancer Care Associates. All rights reserved.","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/"},{"@context":"http:\/\/schema.org","@type":"LocalBusiness","address":{"@type":"PostalAddress","streetAddress":"Corporate Office 25 Main Street, Suite 601","postalCode":"07601","addressRegion":"NJ","addressLocality":"Hackensack","addressCountry":"USA","name":"Postal Address","@id":"https:\/\/www.regionalcancercare.org\/#PostalAddress"},"logo":{"@type":"ImageObject","width":"1024","height":"468","url":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg"},"image":{"@id":"https:\/\/www.regionalcancercare.org\/wp-content\/themes\/rccah\/dist\/images\/RCCA_logo.jpg"},"contactPoint":[{"@type":"ContactPoint","contactOption":"https:\/\/www.regionalcancercare.org\/contact\/#ContactPointOption","availableLanguage":"https:\/\/en.wikipedia.org\/wiki\/English_language","areaServed":["https:\/\/en.wikipedia.org\/wiki\/New_Jersey","https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey"],"contactType":"customer support","telephone":"+1 (844) 346-7222","email":"info@regionalcancercare.org","description":"Corporate Office Regional Cancer Care Associates 25 Main Street, Suite 601 Hackensack, NJ 07601 info@regionalcancercare.org Phone: (844) 346-7222","name":"Contact Corporate Office","image":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2017\/06\/RCCA_logo-300x137.jpg","url":"https:\/\/www.regionalcancercare.org\/contact\/","@id":"https:\/\/www.regionalcancercare.org\/contact\/#CorporateOffice"},{"@type":"ContactPoint","contactOption":"https:\/\/www.regionalcancercare.org\/contact\/#ContactPointOption","availableLanguage":"https:\/\/en.wikipedia.org\/wiki\/English_language","areaServed":["https:\/\/en.wikipedia.org\/wiki\/New_Jersey","https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey"],"contactType":"customer support","telephone":"+1 (201) 510-0922","email":"msalvemini@regionalcancercare.org","description":"Media Inquiries: Mary Lou Salvemini Regional Cancer Care Associates Phone: (201) 510-0922 Email: msalvemini@regionalcancercare.org","name":"Contact Media Inquiries","image":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2017\/06\/RCCA_logo-300x137.jpg","url":"https:\/\/www.regionalcancercare.org\/contact\/","@id":"https:\/\/www.regionalcancercare.org\/contact\/#MediaInquiries"}],"areaServed":["https:\/\/en.wikipedia.org\/wiki\/Hackensack,_New_Jersey","https:\/\/en.wikipedia.org\/wiki\/New_Jersey"],"additionalType":"https:\/\/en.wikipedia.org\/wiki\/Treatment_of_cancer","alternateName":"RCCA","description":"Leaders in Advanced Compassionate Cancer Care. Fight cancer with leading-edge treatments, experienced skill and local caring\/convenience from one of the nation's largest networks of cancer specialists.","email":"info@regionalcancercare.org","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/","url":"https:\/\/www.regionalcancercare.org\/","sameAs":["https:\/\/twitter.com\/rgnlcancercare","https:\/\/www.facebook.com\/regionalcancercareassoc","https:\/\/www.linkedin.com\/company\/10059183","https:\/\/www.youtube.com\/channel\/UCFlVzU4UvZcyXBCe9ZSvAUQ"],"telephone":"+1 (844) 346-7222","name":"Regional Cancer Care Associates","@id":"https:\/\/www.regionalcancercare.org\/"}],{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.regionalcancercare.org\/news\/#breadcrumbitem"},{"@type":"ListItem","position":2,"name":"Applying the Gleason Score to Prostate Cancer","item":"https:\/\/www.regionalcancercare.org\/news\/applying-the-gleason-score-to-prostate-cancer\/#breadcrumbitem"}]}]